Diabetes in pregnancy: are we providing the best care ... - HQIP

A description of women and babies in the enquiry
Table 5.2
Specifi c diabetes complications in women in the enquiry
Specific diabetes complication
Women in the enquiry
n/N (%)
Recurrent hypoglycaemia during pregnancy 203/400 (51)
Hypoglycaemia requiring external help 63/311 (20)
Pre-existing retinopathy 73/316 (23)
New retinopathy 29/316 (9)
Nephropathy 42/359 (12)
5.3 The babies
5.3.1 Pregnancy outcomes
The outcomes of all pregnancies in the enquiry are shown in table 5.3.
Table 5.3
Outcome of pregnancies in the enquiry
No congenital anomaly
(N=315)
Congenital anomaly
(N=127)
Total
(N=442)
Alive at 28 days 220 66 286
Loss before 20 weeks N/A a 19 19
Late fetal loss 13 26 39
Stillbirth 71 6 77
Early neonatal death 9 4 13
Late neonatal death 2 6 8
a
Not within defi nition of pregnancies sampled for enquiry
Gender was known for 385 of 442 offspring. There were 192 males, 192 females and one
indeterminate sex.
5.3.2 Fetal growth restriction
Thirty seven babies in the enquiry had documented antenatal evidence of fetal growth restriction or poor
growth velocity (table 5.4). Seventy percent (26/37) of these babies had a poor outcome (death and/or fetal
congenital anomaly) compared with 50% (222/442) of all babies in the enquiry. There was no difference in
the distribution of type of diabetes or ethnicity amongst women whose babies had fetal growth restriction
(table 5.4). However, 31% of the women whose babies had antenatal evidence of fetal growth restriction
had nephropathy compared to 12% of women in the whole enquiry sample (p=0.002).
20